Cholesterol Interaction Directly Enhances Intrinsic Activity of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
31 07 2019
Historique:
received: 09 07 2019
revised: 23 07 2019
accepted: 29 07 2019
entrez: 3 8 2019
pubmed: 3 8 2019
medline: 17 4 2020
Statut: epublish

Résumé

The recent cryo-electron microscopy structures of zebrafish and the human cystic fibrosis transmembrane conductance regulator (CFTR) provided unprecedented insights into putative mechanisms underlying gating of its anion channel activity. Interestingly, despite predictions based on channel activity measurements in biological membranes, the structure of the detergent purified, phosphorylated, and ATP-bound human CFTR protein did not reveal a stably open conduction pathway. This study tested the hypothesis that the functional properties of the detergent solubilized CFTR protein used for structural determinations are different from those exhibited by CFTR purified under conditions that retain associated lipids native to the membrane. It was found that CFTR purified together with phospholipids and cholesterol using amphipol: A8-35, exhibited higher rates of catalytic activity, phosphorylation dependent channel activation and potentiation by the therapeutic compound, ivacaftor, than did CFTR purified in detergent. The catalytic activity of phosphorylated CFTR detergent micelles was rescued by the addition of phospholipids plus cholesterol, but not by phospholipids alone, arguing for a specific role for cholesterol in modulating this function. In summary, these studies highlight the importance of lipid interactions in the intrinsic activities and pharmacological potentiation of CFTR.

Identifiants

pubmed: 31370288
pii: cells8080804
doi: 10.3390/cells8080804
pmc: PMC6721619
pii:
doi:

Substances chimiques

CFTR protein, human 0
Micelles 0
Phospholipids 0
Polymers 0
Propylamines 0
amphipol A8-35 0
Cystic Fibrosis Transmembrane Conductance Regulator 126880-72-6
Adenosine Triphosphate 8L70Q75FXE
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : BPF-144483
Pays : Canada

Références

Nature. 2005 Feb 24;433(7028):876-80
pubmed: 15729345
Mol Pharmacol. 2018 Aug;94(2):917-925
pubmed: 29903751
J Gen Physiol. 2004 May;123(5):599-621
pubmed: 15111647
Cell. 1991 Feb 22;64(4):681-91
pubmed: 1705179
J Lipid Res. 2013 Feb;54(2):496-502
pubmed: 23172659
Nat Struct Mol Biol. 2007 Aug;14(8):738-45
pubmed: 17660831
Cell. 2017 Mar 23;169(1):85-95.e8
pubmed: 28340353
Nature. 2017 Jun 22;546(7659):504-509
pubmed: 28554189
FEBS Lett. 2011 Nov 16;585(22):3533-7
pubmed: 22020218
FEBS Lett. 2003 Jan 30;535(1-3):141-6
pubmed: 12560093
Cell. 2017 Jul 27;170(3):483-491.e8
pubmed: 28735752
Nat Struct Mol Biol. 2018 Apr;25(4):333-340
pubmed: 29610494
J Gen Physiol. 2018 Apr 2;150(4):539-570
pubmed: 29581173
J Biol Chem. 2004 Oct 1;279(40):41664-9
pubmed: 15284228
J Gen Physiol. 2019 Jul 1;151(7):912-928
pubmed: 31164398
Protein Sci. 2014 Jun;23(6):769-89
pubmed: 24652590
J Gen Physiol. 2019 Jun 3;151(6):834-849
pubmed: 31048413
Nature. 2016 Sep 1;537(7618):117-121
pubmed: 27556947
Anal Biochem. 1988 Jan;168(1):1-4
pubmed: 2834977
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18607-12
pubmed: 25512535
Biosci Biotechnol Biochem. 2005 Jan;69(1):255-7
pubmed: 15665501
Nat Commun. 2017 Oct 2;8(1):764
pubmed: 28970495
J Biol Chem. 2002 Sep 27;277(39):36697-705
pubmed: 12119303
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Methods Enzymol. 2009;464:211-31
pubmed: 19903557
J Cyst Fibros. 2014 Jan;13(1):29-36
pubmed: 23891399
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18825-30
pubmed: 19846789
EMBO J. 2010 Jan 6;29(1):263-77
pubmed: 19927121
Nature. 1997 Sep 18;389(6648):294-6
pubmed: 9305845
Biochem J. 1997 Oct 1;327 ( Pt 1):17-21
pubmed: 9355728
J Biol Chem. 2012 Oct 26;287(44):36639-49
pubmed: 22942289
Biochim Biophys Acta Biomembr. 2017 Feb;1859(2):289-293
pubmed: 27913277
Pflugers Arch. 2007 Feb;453(5):693-702
pubmed: 17021796
Biophys J. 2015 Jul 7;109(1):85-94
pubmed: 26153705
Pflugers Arch. 2003 Mar;445(6):674-82
pubmed: 12632187
Biochim Biophys Acta. 1999 Dec 6;1461(2):275-83
pubmed: 10581361
Arch Biochem Biophys. 2008 Aug 1;476(1):95-100
pubmed: 18417076
FEBS Lett. 2002 Sep 25;528(1-3):251-6
pubmed: 12297315
Cell. 2016 Dec 1;167(6):1586-1597.e9
pubmed: 27912062
Biophys J. 2008 May 1;94(9):3523-37
pubmed: 18192360
Elife. 2016 Jun 21;5:
pubmed: 27328319
Biochem J. 2007 Jan 15;401(2):581-6
pubmed: 16989640
Am J Physiol Lung Cell Mol Physiol. 2010 Mar;298(3):L304-14
pubmed: 20008117
J Physiol. 2009 May 15;587(Pt 10):2151-61
pubmed: 19332488
Biochim Biophys Acta. 2014 Nov;1838(11):2825-37
pubmed: 25065669
Science. 1985 Nov 29;230(4729):1054-7
pubmed: 2997931
J Biol Chem. 1996 Nov 8;271(45):28463-8
pubmed: 8910473
J Biol Chem. 1993 May 25;268(15):11304-11
pubmed: 7684377
Biochim Biophys Acta. 2011 Sep;1808(9):2313-21
pubmed: 21651889
J Physiol. 2007 Aug 1;582(Pt 3):1205-17
pubmed: 17525113
Methods Mol Med. 2002;70:143-57
pubmed: 11917519
Science. 2019 Jun 21;364(6446):1184-1188
pubmed: 31221859
J Vis Exp. 2018 Jul 5;(137):
pubmed: 30035760
Anal Chem. 2012 Jul 17;84(14):6128-35
pubmed: 22703540
J Vis Exp. 2015 Mar 09;(97):
pubmed: 25867140
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12757-12762
pubmed: 30459277
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4404-9
pubmed: 23440202
Eur Biophys J. 2014 Jul;43(6-7):341-6
pubmed: 24771136
J Biol Chem. 2001 Apr 13;276(15):11575-81
pubmed: 11124965
PLoS One. 2013 Sep 18;8(9):e74347
pubmed: 24058550
J Biol Chem. 1996 May 17;271(20):11623-6
pubmed: 8662751
Cell. 1992 Feb 21;68(4):809-18
pubmed: 1371239
Biochem J. 2008 Jun 1;412(2):315-21
pubmed: 18241200
Nature. 2006 Mar 23;440(7083):477-83
pubmed: 16554808
Structure. 2018 Aug 7;26(8):1072-1079.e4
pubmed: 29937358
Sci Rep. 2018 Mar 16;8(1):4664
pubmed: 29549268
Science. 1989 Sep 8;245(4922):1073-80
pubmed: 2570460
Methods Enzymol. 1998;292:492-504
pubmed: 9711577

Auteurs

Stephanie Chin (S)

Programme in Molecular Medicine, Research Institute, Hospital for Sick Children, Toronto, ON M5G0A4, Canada.
Department of Biochemistry, University of Toronto, Toronto, ON M5G0A4, Canada.

Mohabir Ramjeesingh (M)

Programme in Molecular Medicine, Research Institute, Hospital for Sick Children, Toronto, ON M5G0A4, Canada.

Maurita Hung (M)

Programme in Molecular Medicine, Research Institute, Hospital for Sick Children, Toronto, ON M5G0A4, Canada.
Department of Physiology, University of Toronto, Toronto, ON M5G0A4, Canada.

June Ereño-Oreba (J)

Programme in Molecular Medicine, Research Institute, Hospital for Sick Children, Toronto, ON M5G0A4, Canada.

Hong Cui (H)

Programme in Molecular Medicine, Research Institute, Hospital for Sick Children, Toronto, ON M5G0A4, Canada.

Onofrio Laselva (O)

Programme in Molecular Medicine, Research Institute, Hospital for Sick Children, Toronto, ON M5G0A4, Canada.
Department of Physiology, University of Toronto, Toronto, ON M5G0A4, Canada.

Jean-Philippe Julien (JP)

Programme in Molecular Medicine, Research Institute, Hospital for Sick Children, Toronto, ON M5G0A4, Canada.
Department of Biochemistry, University of Toronto, Toronto, ON M5G0A4, Canada.
Department of Immunology, University of Toronto, Toronto, ON M5G0A4, Canada.

Christine E Bear (CE)

Programme in Molecular Medicine, Research Institute, Hospital for Sick Children, Toronto, ON M5G0A4, Canada. bear@sickkids.ca.
Department of Biochemistry, University of Toronto, Toronto, ON M5G0A4, Canada. bear@sickkids.ca.
Department of Physiology, University of Toronto, Toronto, ON M5G0A4, Canada. bear@sickkids.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH